Lung cancer clues found in chest fluid
NCT ID NCT07012759
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking for new biological markers in the fluid that builds up around the lungs (pleural effusion) in people with lung adenocarcinoma. Researchers will compare these markers between cancerous and non-cancerous fluid samples from 100 patients. The goal is to see if these markers can help doctors diagnose lung cancer more accurately.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new diagnostic test that helps doctors identify lung adenocarcinoma from pleural fluid more accurately.
- What could go wrong
- This is an early-stage biomarker study, not a treatment trial. The markers may not prove reliable enough for routine clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOMARKERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fu Jen Catholic University Hospital, Fu Jen Catholic University
RECRUITINGNew Taipei City, 24352, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- Can AI be a Pathologist's second opinion?
- Disposable scope takes on gold standard in pleural diagnosis
- Could a simple chemical wash replace surgery for trapped lungs?
- Zirconia vs titanium: which dental implant heals bone better?
- Blood tests could unlock early clues for three major lung diseases